Among the nonplatinum antitumor drugs, gold (III)‐dithiocarbamato derivatives have recently
attracted considerable attention due to their strong in vitro and in vivo antiproliferative activity …

We synthesized eight new bipyridine and bipyrimidine gold (III) dithiocarbamate-containing
complexes (C1–C8) and tested them in a panel of human cancer cell lines. We used …

At present, cisplatin (cis-diamminodichloroplatinum (II)) is one of the most largely employed
anticancer drugs as it is effective in the treatment of 70− 90% of testicular and, in …

Gold (III)‐dithiocarbamato complexes have recently gained increasing attention as potential
anticancer agents because of their strong tumor cell growth–inhibitory effects, generally …

We synthesized, characterized and tested in a panel of cancer cell lines, nine new bipyridine
gold (III) dithiocarbamate-containing complexes. In vitro studies demonstrated that …

Although gold compounds are now recognized as promising anticancer agents, so far only
gold (I) derivatives have been investigated for this purpose, whereas the use of gold (III) …

In this review paper we aim at giving a detailed overview on our research work devoted to
the design of gold-based anticancer agents. In particular, during the last decade, we have …

New thiolate gold (I) complexes with P (NMe2) 3 (HMPT) as a phosphane group [Au
(SR)(HMPT)](SR= Spy, Spyrim, SMe2pyrim, Sbenzothiazole, Sthiazoline, Sbenzimidazole …

New mixed gold (III) derivatives with dithiocarbamate and thiolate ligands have been
synthesized and characterized. They display high anticancer activity against colon cancer …

Abstract [Au (MSDT) Cl 2](dichloro [methyl N-(dithiocarboxy-kS, kS′)-N-methylglicinato]
gold (III)) and [Au (MSDT) Br 2](dibromo [methyl N-(dithiocarboxy-kS, kS′)-N …